Analyst Price Targets — IKT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 10, 2026 11:32 am | — | Oppenheimer | $5.00 | $1.67 | TheFly | Inhibikase Therapeutics initiated with an Outperform at Oppenheimer |
| December 11, 2025 12:57 pm | Olivia Brayer | Cantor Fitzgerald | $4.00 | $1.50 | TheFly | Inhibikase Therapeutics initiated with an Overweight at Cantor Fitzgerald |
| November 8, 2024 8:22 am | Dennis Ding | Jefferies | $8.00 | $2.78 | StreetInsider | Jefferies Starts Inhibikase Therapeutics Inc (IKT) at Buy |
| October 11, 2024 11:20 am | Edward White | H.C. Wainwright | $5.00 | $1.42 | TheFly | Inhibikase Therapeutics price target lowered to $5 from $15 at H.C. Wainwright |
Latest News for IKT
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), today announced that it has sold 25,000,000 shares of the Company's common stock to RA Capital Management through its at-the-market (“ATM”) facility for gross proceeds of $50 million.
WILMINGTON, Del., July 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 981,243 shares of the Company's common stock to seven newly-hired non-executive employees under the Company's 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of June 30,…
WILMINGTON, Del., May 12, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended March 31, 2026, and highlighted recent developments.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IKT.
U.S. House Trading
No House trades found for IKT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.